Literature DB >> 9073023

Current views on geographic distribution and modes of infection of neurohelminthic diseases.

K Nishimura1, T Hung.   

Abstract

Neurohelminthiases are more prevalent in geographic areas where environmental factors and poor sanitary conditions favor the parasitism between man and animals. In recent years, population shifts and rapid transport have facilitated the spread of certain helminthic diseases from endemic to non-endemic areas. Although many helminthic parasites are known to cause various human diseases afflicting many millions of people in the world, neurohelminthiases are often not diagnosed because they have been unrecognized by clinicians or confirmatory diagnostic tests are not easily available. Paragonimiasis and schistosomiasis (fluke diseases) are endemic in Asia, Africa and Central America; lesions in the central nervous system (CNS) due to ectopic parasitism of the preadult and adult flukes produce various clinical features that often mimic other diseases. In most cestodiasis (tapeworm disease), the adult worm that lodges in the alimentary tract does not involve the CNS; however, the larvae often enter the nervous system by migration or by metastasis via the systemic circulation, where they cause cystic lesions. Cysticercosis is the most common CNS helminthic infection especially in endemic areas where the parasitism between man and pigs is maintained. In other cestodiases, infections to man are often caused by ingestion of food or water contaminated with feces of the definitive hosts (mammals or man). Nematodes (roundworms) generally enter the CNS by ectopic migration of the infective larvae (larva migrans); the routes of infection to man vary with species of the nematodes, and the animal hosts they infest. Angiostrongylus cantonensis is a neurotropic nematode that requires the CNS of mammalian hosts for its growth; the third-stage larvae frequently invade skeletal muscles and the nervous system. Strongyloides, a gastrointestinal nematode, is known to cause CNS involvement in immunosuppressed patients. Recently, some nematodes heretofore unknown to cause human parasitism have been recognized as the causative agents of CNS infections.

Entities:  

Mesh:

Year:  1997        PMID: 9073023     DOI: 10.1016/s0022-510x(96)00293-6

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  The unique Morgue ubiquitination protein is conserved in a diverse but restricted set of invertebrates.

Authors:  Ying Zhou; Zachary W Carpenter; Gregory Brennan; John R Nambu
Journal:  Mol Biol Evol       Date:  2009-07-14       Impact factor: 16.240

2.  First human case of fatal Halicephalobus gingivalis meningoencephalitis in Australia.

Authors:  Chuan Kok Lim; April Crawford; Casey V Moore; Robin B Gasser; Renjy Nelson; Anson V Koehler; Richard S Bradbury; Rick Speare; Deepak Dhatrak; Gerhard F Weldhagen
Journal:  J Clin Microbiol       Date:  2015-02-18       Impact factor: 5.948

3.  Halicephalobus gingivalis: a rare cause of fatal meningoencephalomyelitis in humans.

Authors:  Bhavesh Papadi; Carole Boudreaux; J Allan Tucker; Blaine Mathison; Henry Bishop; Mark E Eberhard
Journal:  Am J Trop Med Hyg       Date:  2013-03-18       Impact factor: 2.345

4.  Angiostrongylus cantonensis infection induces MMP-9 and causes tight junction protein disruption associated with Purkinje cell degeneration.

Authors:  Shih-Chan Lai; Cheng-You Lu; Ling-Yuh Shyu; Ke-Min Chen
Journal:  Parasitol Res       Date:  2020-08-13       Impact factor: 2.289

5.  Identification and specificity of a 38 kDa Loa loa antigenic fraction in sera from high-microfilaraemic Gabonese patients.

Authors:  A Walker-Deemin; A Ferrer; F Gauthier; M Kombila; D Richard-Lenoble
Journal:  Parasitol Res       Date:  2003-11-25       Impact factor: 2.289

Review 6.  The significance of matrix metalloproteinases in parasitic infections involving the central nervous system.

Authors:  Fabrizio Bruschi; Barbara Pinto
Journal:  Pathogens       Date:  2013-02-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.